Regulatory requirements for a private label salicylic acid cleanser depend on your target market, but in most regions—including the United States, Europe, Canada, and Australia—a salicylic acid cleanser is classified as an over-the-counter (OTC) drug for acne treatment (not a cosmetic), which triggers mandatory submissions, safety data, and labeling rules that differ from cosmetics. Skipping regulatory compliance can result in product seizure, significant fines, or legal liability if consumers are harmed.
In the United States, the FDA classifies salicylic acid in skincare as a drug (active pharmaceutical ingredient) under the OTC Monograph for Acne Treatment (21 CFR 333.300–310). This means: (1) salicylic acid is approved for acne treatment at 0.5%–5.0% in rinse-off and leave-on products, but your specific formulation must meet the monograph's criteria (correct concentration, pH, stability, and shelf life); (2) you must label the product as an OTC drug, not a cosmetic, with drug facts panel (active ingredient, purpose, use directions, warnings); (3) your product does not require pre-market approval (you do not submit to the FDA before launching), but you must have reasonably available data demonstrating the product meets the monograph's standards, including a safety assessment (usually done by the co-packer or a third-party lab, reviewing raw material specs, formulation stability, and residual contamination); and (4) you must register your facility and list the product with the FDA, which is a one-time, low-cost ($500–2,000) administrative step often handled by the manufacturer or a regulatory consultant. If you fail to register or misclassify the product as cosmetic, the FDA can issue a warning letter, require a recall, or pursue enforcement.
The most common regulatory mistake for private label salicylic acid cleanser makers is misclassifying the product. Founders sometimes label a salicylic acid cleanser as a "cosmetic exfoliant" to avoid drug classification, but any product that claims to treat, prevent, or mitigate acne is a drug by FDA definition. The claim "gentle exfoliating cleanser with 2% salicylic acid" is usually acceptable cosmetic language, but "helps clear acne," "reduces breakouts," or "treats oily skin prone to spots" triggers drug classification. Work with your manufacturer or a regulatory consultant to ensure your marketing claims align with your intended classification.
In the European Union, salicylic acid in rinse-off exfoliating or acne-care cleansers is permitted as a cosmetic ingredient at concentrations up to 2.0% (Annex III of the EU Cosmetics Regulation 1223/2009). The product is classified as a cosmetic (not a drug), and you are NOT required to obtain pre-market approval. However, you must: (1) notify the product in the CPNP (Cosmetic Products Notification Portal), a public registry, within 10 days of placing it on the market; (2) commission a safety assessment by a qualified person (typically a cosmetic toxicologist or dermatologist) confirming the formulation is safe for intended use; the assessment is not submitted to regulators but must be available if requested; (3) ensure a qualified person (often the manufacturer) takes responsibility for the safety assessment; and (4) label the product in the local language(s) of the countries where it is sold, with ingredient declaration in INCI (International Nomenclature of Cosmetic Ingredients) format, net content, manufacturer details, and cautions. There is no formal approval step, but CPNP notification is mandatory and records your product entry into EU commerce; failure to notify can result in market withdrawal and fines up to €100,000+ in some EU countries.
Canada (Health Canada) regulates salicylic acid in skincare as a natural and non-prescription drug for acne treatment. Salicylic acid cleansers are permitted at 0.5%–2.0% in rinse-off formulations and must meet monograph standards (similar to the US) for safety and efficacy. You must: (1) license your facility with Health Canada (Natural and Non-Prescription Health Products Directorate, NNHPD) if manufacturing in Canada, or designate an importer/distributor in Canada to hold the licence if importing; (2) submit a product licence application (PLA) including formulation, safety data, stability data, and manufacturing information; the review typically takes 4–12 weeks; (3) once approved, the product receives a Natural Product Number (NPN) which must appear on all labels; and (4) comply with Canadian labeling in English and French. Private labeling is simpler if your co-packer is already licensed with NNHPD; they can manufacture and handle the licence application, and you reimburse the licensing fee ($200–500 per product).
Australia (Therapeutic Goods Administration, TGA) classifies salicylic acid in cleansers as a therapeutic good (not cosmetic) for acne treatment. Salicylic acid is permitted at concentrations up to 2.0% in rinse-off products and must be registered on the Australian Register of Therapeutic Goods (ARTG) before sale. Registration requires: (1) a completed application form with product details, formulation, and claimed use; (2) a safety assessment (often provided by the manufacturer, confirming raw material specs and stability); (3) proof that the product is manufactured or imported by an approved sponsor (if you are the brand owner, you become the sponsor); and (4) payment of registration fees (AUD $2,000–4,000 depending on application complexity). Processing takes 4–12 weeks. Once registered, the TGA assigns an ARTG number which must be on all Australian product labels.
Japan (PMDA, Pharmaceuticals and Medical Devices Agency) requires a pre-market approval process for salicylic acid in skincare. Japan does not have a monograph system like the US; instead, any salicylic acid cleanser is considered a cosmetic for external use and must be listed with PMDA, with formulation and safety data submitted. The process is more rigorous than other countries and typically requires engaging a local regulatory consultant. Lead time is 8–16 weeks.
Common regulatory requirements across regions: (1) Stability testing—most regulators expect data showing your formulation remains stable (no separation, color shift, pH change, or viscosity drift) over the intended shelf life, typically at room temperature (25 °C) and often at accelerated conditions (40 °C / 75% relative humidity for 8–12 weeks). This does not mean the product is "safe" for all users—it means it does not degrade into something unsafe—but you must have the data available. (2) Microbiological testing—most co-packers include testing for total aerobic microbial count (TAMC) and total yeast & mold count (TYMC) per USP or EP standards to ensure the formula is not contaminated. (3) Raw material specifications and safety data sheets—you should obtain CoA (Certificate of Analysis) from your raw material suppliers confirming purity and identity of the salicylic acid and other actives; this supports your safety claim. (4) Adverse event reporting—once you launch, if a consumer reports an adverse reaction (rash, severe irritation, allergic reaction), most jurisdictions require you to report it to the regulator within a set timeframe (30–90 days, depending on severity and region).
When working with a manufacturer on AJ Cosmo Labs, confirm upfront who handles regulatory compliance. Some co-packers offer full regulatory support (they file, handle CPNP notification, or apply for registration) as part of their service; others provide only safety data and leave compliance to you. A co-packer should: (1) provide a safety assessment or stability report suitable for regulatory submission in your target market; (2) disclose the salicylic acid concentration and raw material source, and confirm it matches the product label; (3) confirm their facility is appropriately licensed or registered in the markets where they manufacture; and (4) provide a Certificate of Insurance and insurance proof that covers product liability. Many vetted manufacturers on AJ Cosmo Labs list their certifications and regulatory capabilities on their profile; if not listed, ask directly before hiring. Do not assume every co-packer is compliant in every market; a US-GMP facility may not be EU-compliant, and an overseas manufacturer may not understand US or Canadian requirements.
Final note: regulatory compliance is not a one-time cost but an ongoing responsibility. After launch, you must monitor for adverse events, ensure your labeling remains compliant (claims do not drift into unauthorized territory), and maintain accurate records of raw materials, batches, and testing. The manufacturer often shares this responsibility, but ultimately, the brand owner (you) is liable if something goes wrong. Budget 5%–10% of your first-year marketing spend for regulatory consultation and compliance infrastructure; it protects your brand and your customers.
Ingredients in this answer: Salicylic Acid
Read the full guide on Private Label Salicylic Acid Cleanser Manufacturer Low MOQ →